Biotin-LC Alpha-Synuclein (1-20) Peptide

Product Name
Biotin-LC Alpha-Synuclein (1-20) Peptide
Product Quantity
4 mg
Catalog Number
LT8704
Sequence
MDVFMKGLSKAKEGVVAAAE
Met-Asp-Val-Phe-Met-Lys-Gly-Leu-Ser-Lys-Ala-Lys-Glu-Gly-Val-Val-Ala-Ala-Ala-Glu
Purity
>95%
Modifications
LCbiot, 1mg/vial
Peptide Type
Human alpha-synuclein research fragment
Scientific Background

Alpha-synuclein's first sixty residues are built from imperfect eleven-residue KTKEGV repeats. Disordered in solution, they fold into an amphipathic helix on contact with acidic phospholipid membranes, and this is how the protein associates with synaptic vesicles. Residues 1 to 20 open that region.

Nothing in this window drives aggregation. The amyloidogenic segment lies further along the chain, which makes the extreme N-terminus useful precisely because it is inert in that respect: it provides a sequence-matched comparator for experiments where a hydrophobic peptide might aggregate, adsorb or behave non-specifically, and a negative control that is genuinely part of the same protein rather than an unrelated sequence.

The window is also biologically distinctive for another reason. Alpha-synuclein is N-terminally acetylated in cells, a modification that stabilises helical structure here and influences membrane affinity, so reagents and antibodies directed at this region may behave differently against acetylated and unmodified protein. The biotin carries a long-chain spacer, holding the sequence clear of a streptavidin surface where crowding would otherwise suppress binding signal.

Research Applications
  • Lipid vesicle and membrane binding assays of the KTKEGV repeat region
  • Non-amyloidogenic reference peptide against NAC-region sequences
  • Characterising antibodies reported to bind the extreme N-terminus
  • Streptavidin capture for surface plasmon resonance of lipid interactions
  • N-terminal anchor point of the overlapping peptide walk
References

1. Initiation and progression of alpha-synuclein pathology in Parkinson's disease. Cellular and Molecular Life Sciences (2022). CMLS 2022

2. The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication. Scientific Reports (2016). Sci Rep 2016

  • 1 Units in Stock
Ask a Question

Add to Cart: